CLINICAL-STUDY OF LUPUS ANTICOAGULANT
- 1 January 1976
- journal article
- research article
- Vol. 48 (4) , 499-509
Abstract
Eighty-three patients with circulating anticoagulants were studied at The New York Hospital [New York, New York, USA]. The lupus-type anticoagulant, an inhibitor of the prothrombin activator complex, was demonstrated in 58 patients. This inhibitor was identified using the blood and tissue thromboplastin inhibition tests. Inhibition by the lupus anticoagulant was augmented in 67% of these patients by a cofactor present in normal plasma. The lupus inhibitor was detected primarily because of an unsuspected abnormal coagulation test. One-half of the patients with the lupus-type anticoagulant did not have systemic lupus erythematosus.This publication has 10 references indexed in Scilit:
- Platelet Function and Coagulation Profile in Lupus ErythematosusAnnals of Internal Medicine, 1974
- MYOCARDIAL INFARCTION IN A PATIENT WITH A CIRCULATING ANTICOAGULANTThe Lancet, 1967
- Clinical Manifestations of Systemic Lupus ErythematosusJAMA, 1964
- Naturally Occurring Species Specific Inhibitor of Human Prothrombin in Lupus Erythematosus.Experimental Biology and Medicine, 1964
- THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS1963
- A Plasma Coagulation Defect in Systemic Lupus Erythematosus Arising from Hypoprothrombinemia Combined with Antiprothrombinase ActivityBlood, 1960
- A DISORDER OF BLOOD COAGULATION IN SYSTEMIC LUPUS ERYTHEMATOSUS 12Journal of Clinical Investigation, 1955
- UNUSUAL MANIFESTATIONS OF DISSEMINATED LUPUS ERYTHEMATOSUSAnnals of Internal Medicine, 1955
- Acquired Circulating Anticoagulants in Systemic "Collagen Disease"Blood, 1955
- AN ACCELERATING PROPERTY OF PLASMA FOR THE COAGULATION OF FIBRINOGEN BY THROMBIN 12Journal of Clinical Investigation, 1954